Non-amnestic mild cognitive impairment is a prominent aspect in Parkinson's disease patients being considered for deep brain stimulation

Basal Ganglia

Volumn 1, Issue 4, 2011, Pages 213-220

  Costello, Angela ^a   Khamees, Hadeel Al ^b   Moriarty, John ^c   Hulse, Natasha ^a   Malik, Irfan ^a   Selway, Richard ^a   Clough, Chris ^a   Ashkan, Keyoumars ^a,d   Samuel, Michael ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b Prince Sultan Military Medical City   (Saudi Arabia)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Deep brain stimulation; Mild cognitive impairment; Neuropsychological profiles; Parkinson's disease

Indexed keywords

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; BRIXTON TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EXECUTIVE FUNCTION; FEMALE; HUMAN; INTELLIGENCE; INTELLIGENCE QUOTIENT; LANGUAGE; LEARNING; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PERCEPTION; PERFORMANCE; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PSYCHOMETRY; RECALL; VERBAL MEMORY;

EID: 83155181377     PISSN: 22105336     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.baga.2011.10.003     Document Type: Article

References (41)

1. Williams A., Gill S., Varma T., Jenkinson C., Quinn N., Mitchell R., et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010, 9(6):581-591.
2. Follett KA, Weaver FM, Stern M, Hur K, Harris C, Luo P, et al. Pallidal versus subthalamic deep brain stimulation for Parkinson's disease. N Engl J Med 2010;362(22):2077-91.
3. Deuschl G, Shade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355(9):896-908.
4. Ashkan K., Wallace B., Bell B.A., Benabid A.L. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: where are we 10years on?. Brit J Neurosurg 2004, 18(1):19-34.
5. Okun M.S., Fernanadez H.H., Wu S.S., Kirsch-Darrow L., Bowers D., Bova F., et al. Cognition and Mood in Parkinson Disease in STN versus GPi DBS: the COMPARE Trial. Ann Neurol 2009, 65(5):586-595.
6. Rogers S.A., Braaten A.J., Woods S.P., Tröster A.I. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006, 5:578-588.
7. Smeding H.M., Speelman J.D., Koning-Haanstra M., Schuurman P., Nijssen P., van Laar T., et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease. Neurology 2006, 66:1830-1836.
8. Rothlind J., Cockshott R., Starr P., Marks W. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease. J Int Neuropsychol Soc 2007, 13:68-79.
9. Saint-Cyr J.A., Trepanier L.L., Kumar R., Lozano A.M., Lang A.E. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000, 123:2091-2108.
10. Contarino M., Daniele A., Sibilia A., Romito L., Bentivoglio A., Albanese A. Cognitive outcome 5years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2007, 78:248-252.
11. York M.K., Dulay M., Macias A., Levin H., Grossman R., Simpson R., et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 2008, 79:789-795.
12. Hariz M., Johansson F., Shamsgovara P., Johansson E., Hariz G., Fagerlund M. Bilateral subthalamic nucleus stimulation in a Parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study. Mov Disord 2000, 15(1):136-139.
13. Morrison C.E., Borod J.C., Perrine K., Beric A., Brin M., Rezai A., et al. Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease. Arch Clin Neuropsychol 2004, 19:165-181.
14. Lang AE, Houeto JL, Krack P, Kubu C, Lyons K, Moro E, et al. Deep brain stimulation: preoperative issues. Mov Disord 2006;14(Suppl. 14):S171-S196.
15. Aarsland D., Bronnick K., Larsen J.P., Tysnes O.B., Alves G. Cognitive impairment in incident, untreated Parkinson's disease. Neurology 2009, 72:1121-1126.
16. Williams-Gray C., Evans J., Goris A., Foltynie T., Ban M., Robbins T., et al. The distinct cognitive syndromes of Parkinson's disease: 5year follow-up of the CamPaIGN cohort. Brain 2009, 132:2958-2969.
17. Aarsland D., Bronnick K., Williams-Gray C., Weintraub D., Marder K., Kulisevsky J., et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010, 75:1062-1069.
18. Janvin C., Larsen J., Aarsland D., Hugdahl K. Subtypes of mild cognitive impairmentin Parkinson's disease: progression to dementia. Mov Disord 2006, 21(9):1343-1349.
19. Smeding HMM, Speelman JD, Huizenga HM, Schuman MD, Schman B. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson Disease. J Neurol Neurosurg Psychiatry 2007;140012 Published Online First: 21May 2009 doi:10.1136/jnnp.2007.140012.
20. Weschsler D. Wechsler Adult Intelligence Scale, 3rd Edition (WAIS-III): Pearson Assessment 1998, Oxford, UK.
21. Nelson HE, Willison JR. National Adult Reading Test Manuel. 2nd ed. NFER-NELSON, UK: Windsor; 1992.
22. Wechsler D. Wechsler Test of Adult Reading (WTAR). Pearson Assessment, UK: Oxford; 2001.
23. Warrington EK. Recognition Memory Test. NFER-NELSON, UK: Windsor; 1984.
24. Coughlan AK, Hollows SE. The Adult Memory and Information Processing Battery (AMIPB). Leeds, UK: St James' University Hospital; 1985.
25. Warrington EK. The Camden Memory Tests. Psychology Press, Erlbaum (UK) Taylor and Francis Ltd, East Sussex, UK; 1996.
26. McKenna P., Warrington E.K. Graded Naming Test 1983, NFER-NELSON, Windsor, UK.
27. Warrington E.K. The Graded Naming Test: a restandardisation. Neuropsychol Rehabil 1997, 7:143-146.
28. Warrington EK, James M. The Visual Object and Space Perception Battery (VOSP). Pearson Assessment, Oxford, UK; 1991.
29. Burgess P.W., Shallice T. Hayling and Brixton Tests. Pearson Assessment 1997, Oxford, UK.
30. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System (D-KEFS). Pearson Assessment, Oxford, UK; 2001.
31. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999, 56:303-308.
32. Rochester L., Hetherington V., Jones D., Nieuwboer A., Willems A., Kwakkel G., et al. Attending to the task: interference effects of functional tasks on walking in Parkinson's disease and the roles of cognition, depression, fatigue, and balance. [Clinical Trial. Controlled Clinical Trial. Journal Article. Research Support, Non-US Gov't]. Arch Phys Med Rehabil 2004, 85(10):1578-1585.
33. Rochester L., Hetherington V., Jones D., Nieuwboer A., Willems A., Kwakkel G., et al. The effect of external rhythmic cues (auditory and visual) on walking during a functional task in homes of people with Parkinson's disease. Arch Phys Med Rehabil 2005, 86:999-1006.
34. Reverberi C., Lavaroni A., Gigli G., Skrap M., Shallice T. Specific impairments of rule induction in different frontal lobe groups. Neuropsychologia 2005, 43:460-472.
35. Foltynie T., Brayne C.E., Robbins T.W., Barker R.A. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004, 127:550-560.
36. Muslimović D., Post B., Speelman J.D., Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005, 65:1239-1245.
37. Henry J.D., Crawford J.R. Verbal fluency deficits in Parkinson's disease: a meta-analysis. JINS 2004, 10:608-622.
38. Caviness J.N., Driver-Dunckley E., Conner D.J., Sabbagh M.N., Henz J.G., Noble B., et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007, 22(9):1272-1277.
39. Weintraub D., Morberg P.J., Culbertson W.C., Duda J.E., Stern M.B. Evidence for impaired encoding and retrieval memory profiles in Parkinson disease. Cog Behav Neurol 2004, 17:195-200.
40. Whitwell J.L., Peterson R.C., Negash S., Weigand S.D., Kantarci K., Ivnik R.J., et al. Patterns of atrophy differ among specific subtypes of mild cognitive impairment. Arch Neurol 2007, 64(8):1130-1138.
41. LeWitt P.A., Rezai A.R., Leehey M.A., Ojemann S.G., Flaherty A.W., Eskandar E.N., et al. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 2011, 10:309-319.